Pediatrix Medical Group, Inc. MD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 150.09M | 174.81M | 174.22M | 165.39M | 162.19M |
| Total Depreciation and Amortization | 23.78M | 23.08M | 22.61M | 21.83M | 23.07M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 73.39M | 48.37M | 47.98M | 42.05M | 22.75M |
| Change in Net Operating Assets | -20.37M | 606.00K | 13.89M | 41.83M | 82.00M |
| Cash from Operations | 226.89M | 246.86M | 258.71M | 271.09M | 290.00M |
| Capital Expenditure | -17.29M | -18.25M | -21.39M | -18.46M | -16.61M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -11.00M | -30.20M | -30.20M | -23.20M | -19.20M |
| Divestitures | 0.00 | 30.00M | 30.00M | 30.00M | 30.00M |
| Other Investing Activities | 7.41M | 8.81M | -1.23M | -6.64M | -4.15M |
| Cash from Investing | -20.88M | -9.64M | -22.81M | -18.30M | -9.95M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -25.20M | -23.83M | -22.45M | -20.75M | -19.38M |
| Issuance of Common Stock | 2.94M | 2.96M | 3.07M | 3.18M | 3.27M |
| Repurchase of Common Stock | -211.28M | -149.10M | -106.57M | -86.68M | -23.29M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -604.00K | -3.11M | -3.14M | -3.25M | -4.42M |
| Cash from Financing | -234.14M | -173.08M | -129.09M | -107.49M | -43.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.14M | 64.15M | 106.80M | 145.30M | 236.23M |